Report Id: PAATM0521
ALS Treatment Market Size by Treatment Outlook (Medication, Stem Cell Therapy), By Distribution Channel Outlook (Hospital Pharmacies, Retail Pharmacies), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast 2023-2028
The ALS Treatment Market is expected to be around US$ 996 Million by 2028 at a CAGR of 6.15% in the given forecast period.
COVID-19 Impact Analysis Report
"Get Latest Updated Reports as per the COVID-19 Impact"
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
- Mitsubishi Tanabe Pharma Corporation
- Otsuka Pharmaceutical Co., Ltd
- BrainStorm Therapeutics
- Biogen Inc.
- Corestem
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
6
REPORT DESCRIPTION
The ALS Treatment Market is expected to be around US$ 996 Million by 2028 at a CAGR of 6.15% in the given forecast period.
Amyotrophic lateral sclerosis is a neurodegenerative disorder. It is the greatest common category of motor neuron disease. Amyotrophic lateral sclerosis is a collection of rare neurological disorders that mainlycontain nerve cells responsible for monitoring voluntary muscle movement. Amyotrophic lateral sclerosis is also known as Lou Gehrig’s disease. The disease affects the action of motor neurons which results in the blockage of messages between brain fibers andmuscle. Amyotrophic lateral sclerosis can occur in aseparate due to mutation in gene which encrypts enzyme copper-zinc superoxide dismutase associated with defect in chromosome 9 and genetic inheritance. Amyotrophic lateral sclerosis disease is more prevalent in men. These deviations caused by genetic inheritance and mutations result in the publication of glutamate, which damages the motor neurons monitoringvolunteer muscles. The common symptoms of ALS contain muscles weakness, spasticity, cramps, respiratory problems, and fasciculation. Amyotrophic lateral sclerosis results in the incapability to respire. This is due to non-functioning of diaphragm and chest muscles caused due to muscle weakness.
The global ALS Treatment market is segregated on the basis of Treatment Outlook as Medication, Stem Cell Therapy, and Others. Based on Distribution Channel Outlook the global ALS Treatment market is segmented in Hospital Pharmacies, Retail Pharmacies, and Others.
The global ALS Treatment market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The ALS Treatment market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Mitsubishi Tanabe Pharma Corporation, Otsuka Pharmaceutical Co., Ltd., BrainStorm Therapeutics, Biogen Inc., Corestem, AB Science, F.Hoffmann-La Roche AG, Biohaven Pharmaceutical, Sun Pharmaceutical, Ionis Pharmaceuticals, Inc., and others are among the major players in the global ALS Treatment market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The ALS Treatment Market has been segmented as below:
ALS Treatment Market, By Treatment Outlook
- Medication
- Stem Cell Therapy
- Others
ALS Treatment Market, By Distribution Channel Outlook
- Hospital Pharmacies
- Retail Pharmacies
- Others
ALS Treatment Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
ALS Treatment Market, By Company
- Mitsubishi Tanabe Pharma Corporation
- Otsuka Pharmaceutical Co., Ltd.
- BrainStorm Therapeutics
- Biogen Inc.
- Corestem
- AB Science
- F.Hoffmann-La Roche AG
- Biohaven Pharmaceutical
- Sun Pharmaceutical
- Ionis Pharmaceuticals, Inc.
The report covers:
- Global ALS Treatment market sizes from 2021 to 2028, along with CAGR for 2023-2028
- Market size comparison for 2023 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
- Global ALS Treatment market trends, covering comprehensive range of consumer trends & manufacturer trends
- Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global ALS Treatment market
- Major market opportunities and challenges in forecast timeframe to be focused
- Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
- Comprehensive company profiles of the key industry players
Report Scope:
The global ALS Treatment market report scope includes detailed study covering underlying factors influencing the industry trends. The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global ALS Treatment market share. Major industry players with significant revenue share include Mitsubishi Tanabe Pharma Corporation, Otsuka Pharmaceutical Co., Ltd., BrainStorm Therapeutics, Biogen Inc., Corestem, AB Science, F.Hoffmann-La Roche AG, Biohaven Pharmaceutical, Sun Pharmaceutical, Ionis Pharmaceuticals, Inc., and others.
Reasons to Buy this Report:
- Gain detailed insights on the ALS Treatment industry trends
- Find complete analysis on the market status
- Identify the ALS Treatment market opportunities and growth segments
- Analyse competitive dynamics by evaluating business segments & product portfolios
- Facilitate strategy planning and industry dynamics to enhance decision making
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Clopidol (CAS 2971-90-6) Market
Robotic Pharmacy Prescription Dispensing Systems Market
Medical non-woven disposable market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Challenges
5. ALS Treatment Market, By Treatment Outlook
5.1. Key Points
5.2. Medication
5.3. Stem Cell Therapy
5.4. Others
6. ALS Treatment Market, By Distribution Channel Outlook
6.1. Key Points
6.2. Hospital Pharmacies
6.3. Retail Pharmacies
6.4. Others
7. Competitive Landscape
7.1. Introduction
7.2. Recent Developments
7.2.1. Mergers & Acquisitions
7.2.2. New Product Developments
7.2.3. Portfolio/Production Capacity Expansions
7.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
7.2.5. Others
8. Company Profiles
8.1 Mitsubishi Tanabe Pharma Corporation
8.1.1 Company Overview
8.1.2 Product/Service Landscape
8.1.3 Financial Overview
8.1.4 Recent Developments
8.2 Otsuka Pharmaceutical Co., Ltd.
8.2.1 Company Overview
8.2.2 Product/Service Landscape
8.2.3 Financial Overview
8.2.4 Recent Developments
8.3 BrainStorm Therapeutics
8.3.1 Company Overview
8.3.2 Product/Service Landscape
8.3.3 Financial Overview
8.3.4 Recent Developments
8.4 Biogen Inc.
8.4.1 Company Overview
8.4.2 Product/Service Landscape
8.4.3 Financial Overview
8.4.4 Recent Developments
8.5 Corestem
8.5.1 Company Overview
8.5.2 Product/Service Landscape
8.5.3 Financial Overview
8.5.4 Recent Developments
8.6 AB Science
8.6.1 Company Overview
8.6.2 Product/Service Landscape
8.6.3 Financial Overview
8.6.4 Recent Developments
8.7 F.Hoffmann-La Roche AG
8.7.1 Company Overview
8.7.2 Product/Service Landscape
8.7.3 Financial Overview
8.7.4 Recent Developments
8.8 Biohaven Pharmaceutical
8.8.1 Company Overview
8.8.2 Product/Service Landscape
8.8.3 Financial Overview
8.8.4 Recent Developments
8.9 Sun Pharmaceutical
8.9.1 Company Overview
8.9.2 Product/Service Landscape
8.9.3 Financial Overview
8.9.4 Recent Developments
8.10 Ionis Pharmaceuticals, Inc.
8.10.1 Company Overview
8.10.2 Product/Service Landscape
8.10.3 Financial Overview
8.10.4 Recent Developments
The ALS Treatment Market has been segmented as below:
ALS Treatment Market, By Treatment Outlook
- Medication
- Stem Cell Therapy
- Others
ALS Treatment Market, By Distribution Channel Outlook
- Hospital Pharmacies
- Retail Pharmacies
- Others
ALS Treatment Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
ALS Treatment Market, By Company
- Mitsubishi Tanabe Pharma Corporation
- Otsuka Pharmaceutical Co., Ltd.
- BrainStorm Therapeutics
- Biogen Inc.
- Corestem
- AB Science
- F.Hoffmann-La Roche AG
- Biohaven Pharmaceutical
- Sun Pharmaceutical
- Ionis Pharmaceuticals, Inc.
Got a question? We've got answers. If you have some other questions, see our support center.
What is the predicted growth rate of ALS Treatment Market?
The market is expected to grow at a CAGR of 6.15% during the study period (2023-2028)
How big is the ALS Treatment Market value?
The ALS Treatment Market is expected to be around US$ 995 Million by 2028
What is the segment’s covered for the ALS Treatment Market?
The segment included in the ALS Treatment Market is Treatment, Distribution Channel and Region.
Who are the major key vendors in the ALS Treatment Market?
Some key players operating in the ALS Treatment Market include Mitsubishi Tanabe Pharma Corporation, Otsuka Pharmaceutical Co., Ltd., BrainStorm Therapeutics, Biogen Inc., Corestem, AB Science
What are the different forms of the report available?
We can offer several formats of the market research reports including,
• PDF
• PPT
• Spreadsheet/ Workbook
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE